Judith Smith, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · James Petros MD Inc · 21 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Judith Smith’s office at (408) 528-8833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G16304 · Current
Licensed to practise in California · since 1969 · expires 2027-01-31 · Dalhousie University Faculty of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$25,205
Pharmacies billed $25,205 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 53% of their Part D prescriptions (327 of 620) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 15% of their opioid prescriptions.
604 generic and 16 brand-name prescriptions · $25,205 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 169 | $5,174 | $31 |
| Buprenorphine-Naloxone | 26 | $4,817 | $185 |
| Gabapentin | 73 | $1,859 | $25 |
| Oxycodone | 63 | $1,377 | $22 |
| Morphine Sulfate Er | 24 | $843 | $35 |
See all 13 drugs
| Hydrocodone-Acetaminophen | 169 | $5,174 | $31 |
| Buprenorphine-Naloxone | 26 | $4,817 | $185 |
| Gabapentin | 73 | $1,859 | $25 |
| Oxycodone | 63 | $1,377 | $22 |
| Morphine Sulfate Er | 24 | $843 | $35 |
| Buprenorphine | 35 | $374 | $11 |
| Oxycodone-Acetaminophen | 21 | $364 | $17 |
| Amitriptyline | 12 | $284 | $24 |
| Tizanidine | 20 | $233 | $12 |
| Cyclobenzaprine | 27 | $165 | $6 |
| Celecoxib | 22 | $135 | $6 |
| Baclofen | 12 | $134 | $11 |
| Tramadol | 26 | $111 | $4 |
Year by year
| 2024 | 620 | 76 | 53% (327) | 3% | $25,205 |
| 2023 | 641 | 119 | 57% (362) | 3% | $24,657 |
| 2022 | 179 | 53 | 48% (85) | None | $6,723 |
| 2020 | 266 | 39 | 27% (72) | None | $13,288 |
| 2019 | 259 | 60 | 69% (178) | 12% | $22,955 |
| 2018 | 778 | 119 | 70% (544) | 6% | $28,060 |
| 2017 | 615 | 91 | 74% (456) | 4% | $19,168 |
| 2014 | 13 | None | 100% (13) | 0% | $340 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Hydrocodone-Acetaminophen | 185 | $5,955 | $32 |
| Morphine Sulfate Er | 42 | $1,216 | $29 |
| Gabapentin | 61 | $1,133 | $19 |
| Oxycodone-Acetaminophen | 36 | $1,085 | $30 |
| Oxycodone | 48 | $891 | $19 |
| Buprenorphine | 24 | $853 | $36 |
| Amitriptyline | 13 | $750 | $58 |
| Celecoxib | 19 | $675 | $36 |
| Buprenorphine-Naloxone | 14 | $563 | $40 |
| Diclofenac | 11 | $338 | $31 |
| Cyclobenzaprine | 28 | $317 | $11 |
| Baclofen | 19 | $244 | $13 |
| Trazodone | 13 | $238 | $18 |
| Tramadol | 27 | $208 | $8 |
2022: 3 drugs
| Hydrocodone-Acetaminophen | 46 | $1,244 | $27 |
| Oxycodone-Acetaminophen | 11 | $570 | $52 |
| Cyclobenzaprine | 16 | $413 | $26 |
2020: 7 drugs
| Buprenorphine-Naloxone | 16 | $4,156 | $260 |
| Buprenorphine | 23 | $2,127 | $92 |
| Gabapentin | 39 | $804 | $21 |
| Hydrocodone-Acetaminophen | 34 | $743 | $22 |
| Tizanidine | 12 | $184 | $15 |
| Cyclobenzaprine | 18 | $177 | $10 |
| Tramadol | 25 | $146 | $6 |
2019: 7 drugs
| Oxycontin | 11 | $5,037 | $458 |
| Buprenorphine-Naloxone | 15 | $2,737 | $182 |
| Hydrocodone-Acetaminophen | 92 | $2,471 | $27 |
| Buprenorphine | 15 | $1,139 | $76 |
| Oxycodone-Acetaminophen | 19 | $993 | $52 |
| Oxycodone | 13 | $296 | $23 |
| Tramadol | 16 | $145 | $9 |
2018: 15 drugs
| Hydrocodone-Acetaminophen | 181 | $3,869 | $21 |
| Oxycodone-Acetaminophen | 105 | $3,834 | $37 |
| Oxycodone | 119 | $2,773 | $23 |
| Morphine Sulfate Er | 52 | $1,740 | $33 |
| Celecoxib | 12 | $1,434 | $119 |
| Gabapentin | 46 | $778 | $17 |
| Baclofen | 16 | $489 | $31 |
| Sumatriptan | 15 | $484 | $32 |
| Methadone | 28 | $278 | $10 |
| Cyclobenzaprine | 28 | $263 | $9 |
| Acetaminophen-Codeine | 18 | $185 | $10 |
| Tramadol | 12 | $130 | $11 |
| Diazepam | 20 | $110 | $6 |
| Carisoprodol | 13 | $88 | $7 |
| Omeprazole | 12 | $78 | $6 |
2017: 14 drugs
| Oxycodone-Acetaminophen | 92 | $5,526 | $60 |
| Oxycodone | 88 | $3,084 | $35 |
| Hydrocodone-Acetaminophen | 141 | $2,291 | $16 |
| Morphine Sulfate Er | 40 | $1,834 | $46 |
| Fentanyl | 13 | $1,537 | $118 |
| Gabapentin | 23 | $810 | $35 |
| Acetaminophen-Codeine | 20 | $337 | $17 |
| Methadone | 19 | $305 | $16 |
| Hydromorphone | 13 | $245 | $19 |
| Diazepam | 19 | $136 | $7 |
| Cyclobenzaprine | 18 | $110 | $6 |
| Carisoprodol | 15 | $107 | $7 |
| Tramadol | 24 | $87 | $4 |
| Omeprazole | 11 | $72 | $7 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 13 | $340 | $26 |
Money from drug and device companies
$84 in 2025
| 2025 | 2 | 2 | None | $84 |
| 2024 | 2 | 4 | None | $97 |
| 2023 | 1 | 4 | None | $125 |
| 2022 | 1 | 4 | None | $112 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mml US | Reactiv8 | $58 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $26 | 1 payment
|
See all 2 published payments
| Mml US | Meals · 2025-09-25 | Reactiv8 | $58 |
| SPR Therapeutics | Meals · 2025-04-10 | Sprint Pns System | $26 |
See earlier years (2024, 2023, 2022)
2024: $97
| SK Life Science | None | $59 | 2 payments
|
| Abbott Laboratories | Proclaim | $39 | 2 payments
|
2023: $125
| SK Life Science | None | $125 | 4 payments
|
2022: $112
| SK Life Science | None | $112 | 4 payments
|
Professional record
- NPI
- 1588770226
- Licence
- CA 16304California G16304: Current · expires 2027-01-31
- Group
- James Petros MD Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 109 Diapian Bay, Alameda, CA, 94502
- NPI first listed
- 2006-08-23
- NPI last updated
- 2018-09-06
This is when the NPI record was last certified, not a medical board exam.